Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Biomet, Inc.
A new report from Informa's Meddevicetracker highlights strong projected growth in the market, explaining the underlying reasons why.
Antios thinks ATI-2173, which employs the Pharmasset liver-targeting chemistry used in HCV blockbuster Sovaldi, can help produce a functional cure in hepatitis B combination therapy.
FDA grants emergency use authorization to OTC COVID-19 testing products as it targets allowing workplaces, schools and communities to access tools needed to screen for the virus rapidly and accurately.
The US agency has granted emergency use authorization to consumer COVID-19 testing products from Quidel, Abbott and BD.
- Other Names / Subsidiaries
- Biomet Biologics, Inc.